Sovaldi (Sofosbuvir) is a direct-acting antiviral medication indicated for the treatment of Chronic Hepatitis C (CHC) infection. On the World Health Organization’s List of Essential Medicines, It is the most effective and safe medicines needed in a health system.
Ledipasvir/sofosbuvir with the trade name of Harvoni is a medication approved for the treatment of patients with chronic hepatitis C genotype 1 infection. This medicine is a combination of two drugs: Ledipasvir and Sofosbuvir inside (co-formulated) into one tablet. It is the first approved medicine that does not require administration with interferon or ribavirin.